在CAPRISA 004研究之后：是时候重新评估艾滋病词汇了。 - Suppr

After CAPRISA 004: time to re-evaluate the HIV lexicon.

作者信息

Cates Willard

机构信息

FHI, Research Triangle Park, NC 27709, USA.

出版信息

Lancet. 2010 Aug 14;376(9740):495-6. doi: 10.1016/S0140-6736(10)61200-7.

DOI:10.1016/S0140-6736(10)61200-7

PMID:20709216

Abstract

摘要

相似文献

After CAPRISA 004: time to re-evaluate the HIV lexicon.

Lancet. 2010 Aug 14;376(9740):495-6. doi: 10.1016/S0140-6736(10)61200-7.

Antiretrovirals for HIV prevention: translating promise into praxis.

Lancet. 2011 Jul 16;378(9787):206-8. doi: 10.1016/S0140-6736(11)61056-8.

Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women.

Lancet. 2011 Jul 16;378(9787):279-81. doi: 10.1016/S0140-6736(11)60878-7.

Early nonresponse for tenofovir regimen.

AIDS Patient Care STDS. 2003 Nov;17(11):603.

The North Carolina contribution to the CAPRISA 004 study: the Global Health Initiative in action.

N C Med J. 2010 Sep-Oct;71(5):490-1.

HIV transmission may be prevented by intravaginal tenofovir ring.

Future Med Chem. 2012 Dec;4(18):2239.

Antiretroviral vaginal gel shows promise against HIV.

Lancet. 2010 Jul 31;376(9738):320. doi: 10.1016/s0140-6736(10)61123-3.

AIDS: Drugs that prevent HIV infection.

Nature. 2011 Jan 20;469(7330):306-7. doi: 10.1038/469306a.

Elvucitabine data released at CROI.

AIDS Patient Care STDS. 2010 Mar;24(3):198.

Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial.

Trials. 2011 Mar 7;12:67. doi: 10.1186/1745-6215-12-67.

引用本文的文献

Human Organotypic Models for Anti-infective Research.

Curr Top Microbiol Immunol. 2021;430:77-99. doi: 10.1007/82_2018_130.

Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides.

PLoS One. 2018 Jun 5;13(6):e0198478. doi: 10.1371/journal.pone.0198478. eCollection 2018.

M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures.

Sci Rep. 2017 Feb 1;7:41018. doi: 10.1038/srep41018.

Differential Mechanisms of Tenofovir and Tenofovir Disoproxil Fumarate Cellular Transport and Implications for Topical Preexposure Prophylaxis.

Antimicrob Agents Chemother. 2015 Dec 28;60(3):1667-75. doi: 10.1128/AAC.02793-15.

Understanding HIV compartments and reservoirs.

Curr HIV/AIDS Rep. 2014 Jun;11(2):186-94. doi: 10.1007/s11904-014-0207-y.

Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product prices.

BMC Infect Dis. 2014 Jan 9;14:14. doi: 10.1186/1471-2334-14-14.

Assessment of a Microbicide Candidate among a Diverse Cohort of Urban Southern US Women and their Male Sexual Partners.

J AIDS Clin Res. 2012 Jul 3;Suppl 4(4). doi: 10.4172/2155-6113.S4-004.

A multi-targeted drug candidate with dual anti-HIV and anti-HSV activity.

PLoS Pathog. 2013;9(7):e1003456. doi: 10.1371/journal.ppat.1003456. Epub 2013 Jul 25.

Incident HSV-2 infections are common among HIV-1-discordant couples.

J Infect Dis. 2013 Oct 1;208(7):1093-101. doi: 10.1093/infdis/jit303. Epub 2013 Jul 9.

Integrating acute HIV infection within routine public health surveillance practices in New York City.

Public Health Rep. 2012 Jul-Aug;127(4):451-9. doi: 10.1177/003335491212700413.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

After CAPRISA 004: time to re-evaluate the HIV lexicon.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献